Skip to content

A Randomized Controlled Trial on Bathing Frequency and Skin Barrier Outcomes in Atopic Dermatitis

A Randomized Controlled Trial on Bathing Frequency and Skin Barrier Outcomes in Atopic Dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126234
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-09
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis (AD)

Interventions

Daily Bathing Group:Daily bathing
Weekly Bathing Group:Weekly Bathing

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 1 year (applicable to both children and adults); 2.Diagnosed with AD by an outpatient dermatologist; 3.Predominantly mild to moderate: Recommended EASI >=1 or POEM >= 3; 4.Treatment has been relatively stable in the past 2 weeks: No new initiation of systemic treatment; The topical anti-inflammatory regimen is stable (allowing routine moisturizing); 5.The subject and/or the guardian understand and are willing to accept randomization, and are able to complete the 8-week follow-up and diary record (either via mobile device or paper).

Exclusion criteria

Exclusion criteria: 1.The main skin lesions are limited to the hands / venous congestion / contact dermatitis, etc., and it is suspected that it is not dominated by AD; or it is combined with other major skin diseases for evaluation (psoriasis, scabies, etc.); 2.Those who need to initiate or adjust systemic treatment in the near future (such as biologics, JAK inhibitors, cyclosporine, MTX, systemic hormones, etc.); 3.Severe skin infections require systemic antibiotic treatment; 4.Plan to swim or soak in hot springs more than twice a week during the follow-up period; 5.Unable to change the bathing frequency or have extremely poor expected compliance; 6.Pregnant / breastfeeding;

Design outcomes

Primary

MeasureTime frame
Week 8 POEM Change (?POEM = Week 8 - Week 0);

Secondary

MeasureTime frame
Itch Numeric Rating Scale (Itch NRS);Atopic Dermatitis Control Tool(ADCT);SCORing Atopic Dermatitis(SCORAD);Frequency/dose of topical anti-inflammatory drugs;Dermatology Life Quality Index (DLQI) score;Investigator's Global Assessment (IGA);Eczema Area and Severity Index(EASI);Transepidermal Water Loss(TEWL);

Countries

China

Contacts

Public ContactAn Jingang

Xi'an Jiaotong University Second Affiliated Hospital

anjg2008@126.com+86 29 87679301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026